General
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the Oxford-AstraZeneca vaccine
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust…
Continue Reading
-
General13 hours ago‘We are here for you’: PM to bring help to flood zones
-
Noosa News23 hours agoPolice to get on-the-spot protection powers for DV victims
-
General11 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Business23 hours agoASX 200 plunges as US tariffs fall-out continues